Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419575 · ClinicalTrials.gov registry record
Renal Transplantation With Immune Monitoring
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 60
- Enrollment target
NCT00419575 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 60 participants.
The verdict
NCT00419575 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The aim of this observational study is to evaluate an FDA approved immune system monitoring assay (Immunknow, Cylex Inc. Columbia, MD) in renal transplant recipients using standard immunosuppression and prophylaxis protocols from the time of transplantation through a twelve month follow-up period. The primary endpoint will be the incidence of acute rejection and infection and any correlation of these events to an assay that may be a measure of recipient immune response. Secondary endpoints will include evaluation of renal function, patient and graft survival, incidence of post-transplantation lymphoproliferative disorder and duration and extent of lymphocyte depletion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00419575
The ClinicalTrials.gov registry entry for NCT00419575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00419575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00419575 about?
NCT00419575 is a clinical study titled "Renal Transplantation With Immune Monitoring". The aim of this observational study is to evaluate an FDA approved immune system monitoring assay (Immunknow, Cylex Inc. Columbia, MD) in renal transplant recipients using standard immunosuppression and prophylaxis protocols from the time of transplantation through a twelve month follow-up period. T...
What is the current status of trial NCT00419575?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2008-05.
Who is sponsoring clinical trial NCT00419575?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.